Read the full interview:
Dual-Mode Vasodilator M119 Delivery to Hair Follicle via Dissolving Microneedle for Advanced Alopecia Treatment.
Read moreTOPADUR in collaboration with the University Hospital of Zurich and the University of Zurich was awarded CHF 859k by Innosuisse.
Read moreThe Switzerland Global Enterprise interviewed Reto Naef, CEO of TOPADUR PHARMA AG.
Read more